pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Biologics and Biosimilars Market Report 2017


Published On : May 2017

Category : Pharmaceutical

No. of Pages : 120 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Biologics and Biosimilars for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biologics and Biosimilars market competition by top manufacturers/players, with Biologics and Biosimilars sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Biologics and Biosimilars for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for Emea europe middle east and africa biologics and biosimilars market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa biologics and biosimilars market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa biologics and biosimilars market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa biologics and biosimilars market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa biologics and biosimilars market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa biologics and biosimilars market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa biologics and biosimilars market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa biologics and biosimilars market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa biologics and biosimilars market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa biologics and biosimilars market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa biologics and biosimilars market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa biologics and biosimilars market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa biologics and biosimilars market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Biologics and Biosimilars
Figure EMEA Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure EMEA Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Biologics and Biosimilars by Application in 2016
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure EMEA Biologics and Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biologics and Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biologics and Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biologics and Biosimilars Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biologics and Biosimilars Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Biologics and Biosimilars Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Players (2012-2017)
Figure 2016 Biologics and Biosimilars Sales Share by Players
Figure 2017 Biologics and Biosimilars Sales Share by Players
Figure EMEA Biologics and Biosimilars Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biologics and Biosimilars Revenue (Million USD) by Players (2012-2017)
Table EMEA Biologics and Biosimilars Revenue Share by Players (2012-2017)
Table 2016 EMEA Biologics and Biosimilars Revenue Share by Players
Table 2017 EMEA Biologics and Biosimilars Revenue Share by Players
Table EMEA Biologics and Biosimilars Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Biologics and Biosimilars Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure EMEA Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Table EMEA Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Type in 2016
Table EMEA Biologics and Biosimilars Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Biologics and Biosimilars Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Application (2012-2017)
Figure EMEA Biologics and Biosimilars Sales Market Share by Application in 2016
Table EMEA Biologics and Biosimilars Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure EMEA Biologics and Biosimilars Sales Market Share in 2016
Table EMEA Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biologics and Biosimilars Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure EMEA Biologics and Biosimilars Revenue Market Share Regions in 2016
Table EMEA Biologics and Biosimilars Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Europe Biologics and Biosimilars Sales (K MT) by Type (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Type (2012-2017)
Figure Europe Biologics and Biosimilars Market Share by Type in 2016
Table Europe Biologics and Biosimilars Sales (K MT) by Application (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Application (2012-2017)
Figure Europe Biologics and Biosimilars Market Share by Application in 2016
Table Europe Biologics and Biosimilars Sales (K MT) by Countries (2012-2017)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries in 2016
Table Europe Biologics and Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Europe Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure Germany Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure France Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure UK Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biologics and Biosimilars Sales (K MT) by Type (2012-2017)
Table Middle East Biologics and Biosimilars Market Share by Type (2012-2017)
Figure Middle East Biologics and Biosimilars Market Share by Type (2012-2017)
Table Middle East Biologics and Biosimilars Sales (K MT) by Applications (2012-2017)
Table Middle East Biologics and Biosimilars Market Share by Applications (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Market Share by Application in 2016
Table Middle East Biologics and Biosimilars Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Biologics and Biosimilars Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Volume Market Share by Countries in 2016
Table Middle East Biologics and Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biologics and Biosimilars Sales (K MT) by Type (2012-2017)
Table Africa Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Type in 2016
Table Africa Biologics and Biosimilars Sales (K MT) by Application (2012-2017)
Table Africa Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Table Africa Biologics and Biosimilars Sales Volume (K MT) by Countries (2012-2017)
Table Africa Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Countries in 2016
Table Africa Biologics and Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Africa Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure South Africa Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Table Pfizer Biologics and Biosimilars Basic Information List
Table Pfizer Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Roche Biologics and Biosimilars Basic Information List
Table Roche Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Roche Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Roche Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Amgen Biologics and Biosimilars Basic Information List
Table Amgen Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Amgen Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Amgen Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table AbbVie Biologics and Biosimilars Basic Information List
Table AbbVie Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure AbbVie Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure AbbVie Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Sanofi Biologics and Biosimilars Basic Information List
Table Sanofi Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Sanofi Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biologics and Biosimilars Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biologics and Biosimilars Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Novartis Biologics and Biosimilars Basic Information List
Table Novartis Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Novartis Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Merck Biologics and Biosimilars Basic Information List
Table Merck Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Merck Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Merck Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Lilly Biologics and Biosimilars Basic Information List
Table Lilly Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lilly Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Lilly Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Lilly Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table 3sbio Biologics and Biosimilars Basic Information List
Table Changchun High Tech Biologics and Biosimilars Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Basic Information List
Table Biotech Pharma Biologics and Biosimilars Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Basic Information List
Table Sandoz Biologics and Biosimilars Basic Information List
Table Teva Biologics and Biosimilars Basic Information List
Table Hospira Biologics and Biosimilars Basic Information List
Table Mylan Biologics and Biosimilars Basic Information List
Table 3sbio Biologics and Biosimilars Basic Information List
Table Changchun High Tech Biologics and Biosimilars Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Basic Information List
Table Biotech Pharma Biologics and Biosimilars Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2016
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure EMEA Biologics and Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biologics and Biosimilars Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Biologics and Biosimilars Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Biologics and Biosimilars Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biologics and Biosimilars Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biologics and Biosimilars Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biologics and Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Biologics and Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biologics and Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biologics and Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biologics and Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Biologics and Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biologics and Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biologics and Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biologics and Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Biologics and Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biologics and Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biologics and Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biologics and Biosimilars Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Biologics and Biosimilars Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biologics and Biosimilars Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Biologics and Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top